基本信息
views: 35
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
The Cell Biology group will innovate and develop assays to validate in-cell efficacy of established and new probe families which include bromodomains, Nudix hydrolases, deaminase and DENN domains. Each assay will be developed to address the unique biology of the target using molecular biology (inc CRISPR, RNAseq, ChIP, Mass Spectrocopy) and confocal microscopy (HTS/HCS). Further detailed investigations into the biological mechanism and disease target will be carried out both in-house and with academic and pharmaceutical industry collaborations. By advancing SGC probes into cellular assays we aim to produce pre-clinical in vitro data to enable the translation of SGC probes into a disease area within the clinic.
Gillian’s research interests include disease heterogeneity, multicellular and 3D disease models.
Gillian’s research interests include disease heterogeneity, multicellular and 3D disease models.
Research Interests
Papers共 97 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Journal of mammary gland biology and neoplasiano. 1 (2024): 9-9
Journal of medicinal chemistryno. 7 (2024): 5837-5853
Brigitt Raux, Karly A. Buchan, James Bennett,Thomas Christott,Matthew S. Dowling,Gillian Farnie,Oleg Fedorov,Vicki Gamble,Carina Gileadi,Charline Giroud,Kilian V. M. Huber,Magdalena Korczynska,
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2024): 129546-129546
John Pollard,Graham Craggs,Gillian Farnie,Matthew Fawkes,Oleg Fedorov,Charline Giroud, Fenella Gross,Joe Harman, Alison Maloney,Thomas Arthur Milne,Iain Simpson
BLOOD (2023)
John Pollard,Graham Craggs,Gillian Farnie,Matthew Fawkes,Oleg Fedorov,Charline Giroud, Fenella Gross,Joe Harman, Alison Maloney,Thomas Arthur Milne,Iain Simpson
Blood (2023): 2789
crossref(2023)
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn